Source: International Congress 2018 – COPD and extrapulmonary comorbidities
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
D. Viglino (Grenoble, France), A. Plazanet (Grenoble, France), S. Bailly (Grenoble, France), M. Benmerad (Grenoble, France), I. Jullian-Desayes (Grenoble, France), R. Tamisier (Grenoble, France), V. Leroy (Grenoble, France), J. Zarski (Grenoble, France), M. Maignan (Grenoble, France), M. Joyeux-Faure (Grenoble, France), J. Pépin (Grenoble, France). Impact of non-alcoholic fatty liver disease on late cardiovascular events and death in Chronic Obstructive Pulmonary Disease. 4038

Member's Comments

No comment yet.

Related content which might interest you: Could Monocyte /HDL cholesterol ratio predict cardiovascular events in patients with Chronic Obstructive Pulmonary Disease ? Source: International Congress 2017 – Systemic and airway biomarkers Year: 2017 Impact of abnormal body water distribution on prognostic of Chronic Obstructive Pulmonary Disease and heart failure patients. Source: Virtual Congress 2020 – Comorbidities/multimorbidites and mortality in patients with chronic lung diseases Year: 2020 The metabolic syndrome in patients with chronic obstructive pulmonary disease Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Role of eosinopenia in predicting mortality and morbidity in patients with Chronic Obstructive Pulmonary Disease (COPD) Source: International Congress 2019 – Airway diseases and blood cells Year: 2019 Predictive factors for readmission of patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease and respiratory failure Source: Respiratory Failure and Mechanical Ventilation Conference 2020 Year: 2020 Disturbed fatty acid metabolism in airway secretions of patients with Chronic Obstructive Pulmonary Disease Source: International Congress 2017 – Translational studies of lung disease Year: 2017 Respiratory, cardiovascular and systemic factors associated with brain damage in Chronic Obstructive Pulmonary Disease (COPD) and/or coronary artery disease (CAD) Source: Virtual Congress 2021 – Comorbidities in airway obstructive diseases Year: 2021 The role of Microalbuminuria as a predictor marker during acute exacerbations of Chronic Obstructive Pulmonary Disease Source: Virtual Congress 2021 – Biomarkers for the management of bronchial obstructive diseases Year: 2021 Impact of concomitant cardiovascular diseases on functional status and quality of life of patients with Chronic Obstructive Pulmonary Diseases Source: International Congress 2019 – From tobacco-related comorbidities to tobacco cessation Year: 2019 Metabolic paralysis in systemic immune cells of Chronic Obstructive Pulmonary Disease (COPD) subjects. Source: International Congress 2018 – Functional genomics and COPD: new challenges Year: 2018 Nonalcoholic fatty liver disease in chronic obstructive pulmonary disease Source: Eur Respir J, 49 (6) 1601923; 10.1183/13993003.01923-2016 Year: 2017 “Asthma-like features” in Chronic Obstructive Pulmonary Disease (COPD) patients Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS) Year: 2018 Metabolic Syndrome (MetS) as a comorbidity of Chronic Obstructive Pulmonary Disease (COPD) Source: Virtual Congress 2021 – Comorbidities in airway obstructive diseases Year: 2021 Chronic obstructive pulmonary disease (COPD) and alterations of hemogram Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 Effectiveness of pulmonary rehabilitation initiated after exacerbation of Chronic Obstructive Pulmonary Disease Source: International Congress 2018 – Aspects of pulmonary rehabilitation and chronic care Year: 2018 Association of Metabolic Syndrome with the severity of Chronic Obstructive Pulmonary Disease Source: Virtual Congress 2020 – Clinical data and COPD management Year: 2020 Chronic Obstructive Pulmonary Disease (COPD) Source: Eur Respir Rev 2009; 18: 133 Year: 2009 Late Breaking Abstract - High blood neutrophils are associated with increased exacerbations and mortality in Chronic Obstructive Pulmonary Disease Source: International Congress 2019 – COPD clinical studies: bronchodilators, corticosteroids and more Year: 2019 Dysfunctional breathing impacts symptom burden in Chronic Obstructive Pulmonary Disease (COPD). Source: Virtual Congress 2020 – Air pollution and comorbidities Year: 2020 Sexuality in Chronic Obstructive Pulmonary Disease (SEXY COPD) Source: Virtual Congress 2020 – Comprehensive care and pulmonary rehabilitation for chronic respiratory diseases Year: 2020